nav-left cat-right

Canagliflozin Amputee Attorney

That negates the study’s findings of cardiac benefit, Buse said, predicting the Canagliflozin amputee attorney FDA would never approve the drug to prevent cardiovascular events based on current data.Dr. Sidney Wolfe, director of the group’s health research, noted that because Invokana worked to lower blood glucose in a whole new way, it was likely to come with previously unknown risks.We have been handling claims against pharmaceutical companies since 1955, and each year we teach more than 1,000 attorneys how to successfully handle these types of cases.Our attorneys are working with patients who have been harmed by Invokana.All fields required.But now we learn the dangers…This new information from the FDA confirms the risk to patients of taking the drug canafliglozin.Bone Fracture Risk—Patients taking Invokana are at increased risk of bone fractures as soon as 12 weeks after starting the medication.A May 2017 FDA Drug Safety Communication stated, "Based on new data from two large clinical trials, the U.S. Food and Drug Administration (FDA) has concluded that the type 2 diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR) causes an increased risk of leg and foot amputations.

Physicians should also monitor patients for ulcers, sores, pain or tenderness "and discontinue canagliflozin if these complications occur," the FDA said.He further explained that "The fact that the drug works by a uniquely new mechanism to lower blood sugar has not spared of a whole set of unique new risks".We are not handing ketoacidosis or kidney injuries.Aside from the increased risk of ketoacidosis, another frequent Invokana side effect is genital fungal infections.Invokana® and Invokamet® are trademarks of Johnson & Johnson Corporation and are used here only to identify the products in question.Millions of Americans with type-2 diabetes may have been prescribed a drug that puts them at serious increased risk of toe, foot and leg amputations.Call today to learn more or to schedule a free consultation on your case.Invokana, which contains the active ingredient canagliflozin, was approved by the FDA in 2013.Although these drugs remain on the market, the FDA continues to issue warnings.

It is supposed to be used in conjunction with diet and exercise.Maintain blood pressure.Why does Invokana cause Amputations?The problem is Invokana does not work properly and can actually exacerbate diabetic complications, leading to patients developing kidney injury and kidney failure, diabetic ketoacidosis, and toe, foot, or leg amputations.We believe that it’s important to maintain a positive, cooperative relationship with the client, so you remain informed throughout the proceedings.Here are a few examples:

Comments are closed.